1. CohenJI (2000) Epstein-Barr virus infection. N Engl J Med 7: 481–492.
2. BornkammGW (2009) Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue. Semin Cancer Biol 19: 351–365.
3. BabcockGJ, DeckerLL, VolkM, Thorley-LawsonD (1998) EBV persistence in memory B cells in vivo. Immunity 9: 395–404.
4. HochbergD, SouzaT, CatalinaM, SullivanJL, LuzuriagaK, et al. (2004) Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 78: 5194–5204.
5. StevenNM (1996) Infectious mononucleosis. EBV Reports 3: 91–95.
6. de-TheG, GeserA, DayNE, TukeiPM, WilliamsEH, et al. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756–761.
7. HenleW, HenleG, HoHC, BurtinP, CachinY, et al. (1970) Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 44: 225–231.
8. LanierAP, CliftSR, BornkammG, HenleW, GoepfertH, et al. (1991) Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland. Arctic Med Res 50: 55–61.
9. ShibataD, TokunagaM, UemuraY, SatoE, TanakaS, et al. (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139: 469–474.
10. WeissLM, MovahedLA, WarnkeRA, SklarJ (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320: 502–506.
11. WeissLM, StricklerJG, WarnkeRA, PurtiloDT, SklarJ (1987) Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129: 86–91.
12. EpsteinM, WoodallJ, ThomsonA (1964) Lymphoblastic lymphoma in bone-marrow of African green monkeys (Cercopithecus aethiops) inoculated with biopsy material from a child with Burkitt's lymphoma. Lancet 2: 288–291.
13. BaerR, BankierAT, BigginMD, DeiningerPL, FarrellPJ, et al. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310: 207–211.
14. UrayamaKY, JarrettRF, HjalgrimH, DiepstraA, KamataniY, et al. (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 104: 240–253.
15. HjalgrimH, RostgaardK, JohnsonPCD, LakeA, ShieldL, et al. (2010) HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA 107: 6400–6405.
16. DiepstraA, NiensM, VellengaE, van ImhoffGW, NolteIM, et al. (2005) Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma. Lancet 365: 2216–2224.
17. McAulayKA, HigginsCD, MacsweenKF, LakeA, JarrettRF, et al. (2007) HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 117: 3042–3048.
18. SundqvistE, SundströmP, LindénM, HedströmAK, AloisiF, et al. (2012) Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 13: 14–20.
19. SundströmP, NyströmL, JidellE, HallmansG (2008) EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult Scler 14: 1120–1122.
20. SpenceA, WestlakeJ, LangeK (1977) Estimation of the variance components for dermal ridge count. Ann Hum Genet 41: 111–115.
21. RubiczR, LeachCT, KraigE, DhurandharNV, DuggiralaR, et al. (2011) Genetic factors influence serological measures of common infections. Hum Hered 72: 133–141.
22. PuppalaS, DoddGD, FowlerS, AryaR, SchneiderJ, et al. (2006) A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 78: 377–392.
23. RubiczR, LeachCT, KraigE, DhurandharNV, GrubbsB, et al. (2011) Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX. BMC Res Notes 21: 433.
24. Rickinson AB, Kieff E (2001) Epstein-Barr virus. In Field's Virology, Knipe, D.M., Howley P.M., Griffin, DE. Martin, M.A., Lamb, R.A., and Roizman, B., ed. (Philadelphia, PA: Lippincott Williams & Wilkins).
25. De PaschaleM, AgrappiC, MancoMT, MirriP, ViganòEF, et al. (2009) Seroepidemiology of EBV and interpretation of the “isolated VCA IgG” pattern. J Med Virol 81: 325–331.
26. PorterDD, WimberlyI, Benyesh-MelnickM (1969) Prevalence of antibodies to EB virus and other herpesviruses. JAMA 208: 1675–1679.
27. BessonC, AmielC, Le-PendevenC, PlancoulaineS, RanqueB, et al. (2009) Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas. J Infect Dis 199: 1121–1127.
28. NemerowGR, MoldC, SchwendVK, TollefsonV, CooperNR (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61: 1416–1420.
29. LiQ, SpriggsMK, KovatsS, TurkSM, ComeauMR, et al. (1997) Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71: 4657–4662.
30. KhanG, MiyashitaEM, YangB, BabcockGJ, Thorley-LawsonDA (1996) Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5: 173–179.
31. Nebel-SchickelH, HindererW, SaavedraC, SchmutzlerR, HornJ, et al. (1994) Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection. Beitr Infusionsther Transfusionsmed 32: 134–137.
32. LevitskayaJ, SharipoA, LeonchiksA, CiechanoverA, MasucciMG (1997) Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94: 12616–12621.
33. ZengY, JanMG, ZhangQ, ZhangLG, LiHY, et al. (1982) Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 29: 139–141.
34. PathmanathanR, PrasadU, SadlerR, FlynnK, Raab-TraubN (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333: 693–698.
35. GlaserSL, GulleyML, ClarkeCA, KeeganTH, ChangET, et al. (2008) Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer 123: 1499–1507.
36. NourseJP, JonesK, GandhiMK (2011) Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenic insights for targeted therapy. Am J Transplant 11: 888–895.
37. HenleG, HenleW, CliffordP, DiehlV, KafukoGW, et al. (1969) Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst 43: 1147–1157.
38. JamesJA, HarleyJB, ScofieldRH (2006) Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 18: 462–467.
39. AscherioA, MungerKL, LennetteET, SpiegelmanD, HernanMA, et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083–3088.
40. ArbuckleMR, ReichlinM, HarleyJB, JamesJA (1999) Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol 50: 447–455.
41. PooleBD, ScofieldRH, HarleyJB, JamesJA (2006) Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39: 63–70.
42. FernandoMMA, FreudenbergJ, LeeA, MorrisDL, BotevaL, et al. (2012) Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis Epub Jan 10.
43. LincolnMR, MontpetitA, CaderMZ, SaarelaJ, DymentDA, et al. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 37: 1108–1112.
44. HandelAE, HandunnetthiL, BerlangaAJ, WatsonCT, MorahanJM, et al. (2010) The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression. PLoS ONE 5: e10142 doi:10.1371/journal.pone.0010142.
45. MitchellBD, KammererCM, BlangeroJ, MahaneyMC, RainwaterDL, et al. (1996) Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 9: 2159–2170.
46. HuntKJ, LehmanDM, AryaR, FowlerS, LeachRJ, et al. (2005) Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study. Diabetes 54: 2655–2662.
47. McPeekMS, SunL (2000) Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet 66: 1076–1094 (2000).
48. ChengML, WoodfordSC, HilburnJL, VandeBergJL (1986) A novel system for storage of sera frozen in small aliquots. J Biochem Biophys Methods 1: 47–51.
49. DhurandharNV, IsraelBA, KolesarJM, MayhewGF, CookME, et al. (2000) Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disor 24: 989–996.
50. AlmasyL, BlangeroJ (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198–1211.
51. SobelE, PappJC, LangeK (2002) Detection and integration of genotyping errors in statistical genetics. Am J Hum Genet 70: 496–508.
52. AbecasisGR, ChernySS, CooksonWO, CardonLR (2002) Merlin–rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30: 97–101.
53. HeathSC (1997) Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 61: 748–760.
54. KongA, GudbjartssonDF, SainzJ, JonsdottirGM, GudjonssonSA, et al. (2002) A high-resolution recombination map of the human genome. Nat Genet 31: 241–247.
55. DuggiralaR, WilliamsJT, Williams-BlangeroS, BlangeroJ (1997) A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol 6: 987–992.
56. WilliamsJT, Van EerdeweghP, AlmasyL, BlangeroJ (1999) Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. Am J Hum Genet 4: 1134–1147.
57. PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.
58. R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
59. PruimRJ, WelchRP, SannaS, TeslovichTM, ChinesPS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336–2337.
60. GöringHHH, CurranJE, JohnsonMP, DyerTD, CharlesworthJ, et al. (2007) Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet 10: 1208–1216.
61. NgCC, YewPY, PuahSM, KrishnanG, YapLF, et al. (2009) A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet 54: 392–397.
62. BeiJX, LiY, JiaWH, FengBJ, ZhouG, et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet 42: 599–603.
63. TseKP, SuWH, ChangKP, TsangNM, YuCJ, et al. (2009) Genome-wide association study reveals multiple nasopharyngeal carcinoma-associateed loci within the HLA region at chromosome 6p21.3. Am J Hum Genet 85: 194–203.
64. ZhaoM, CaiH, LiX, ZhengH, YangX, et al. (2010) Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese. J Transl Med 10: 57.
65. JiaWH, PanHQ, QinHD, XuYF, ShenGP, et al. (2009) A case-control and family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis 30: 2031–2036.
66. QinHD, ShugartYY, BeiJX, PanQH, ChenL, et al. (2011) Comprehensive pahtway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 71: 3000–3008.
67. Encisco-MoraV, BroderickP, MaY, JarrettRF, HjalgrimH, et al. (2010) A genome-wide association of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet 42: 1126–1130.
68. UrayamaKY, JarrettRF, HjalrimH, DiepstraA, KamataniY, et al. (2012) Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status defined subgroups. JNCI 104: 240–253.
69. CozenW, LiD, BestT, Van Den BergDJ, GourraudPA, et al. (2012) A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 119: 469–475.
70. GatevaV, SandlingJK, HomG, TaylorKE, ChungSA, et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228–1233.
71. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) (2008) HarleyJB, Alarcón-RiquelmeME, CriswellLA, JacobCO, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204–210.
72. KyogokuC, LangefeldCD, OrtmannWA, LeeA, SelbyS, et al. (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75: 504–507.
73. KarassaFB, TrikalinosTA, IoannidisJP (2002) Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 46: 563–1571.
74. EdbergJC, LangefeldCD, WuJ, MoserKL, KaufmanKM, et al. (2002) Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum 46: 2132–2140.
75. HanJW, ZhengHF, CuiY, SunLD, YeDQ, et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234–1237.
76. Cunninghame GrahamDS, GrahamRR, MankuH, WongAK, WhittakerJC, et al. (2008) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 40: 83–89.
77. CunninghameG, MorrisDL, BhangaleTR, CriswellLA, SyvänenAC, et al. (2011) Association of NCF2, IKZF1, IRF8, and TYK2 with systemic lupus erythematosus. PLoS Genet 7: e1002341 doi:10.1371/journal.pgen.1002341.
78. HomG, GrahamRR, ModrekB, TaylorKE, OrtmannW, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358: 900–909.
79. GrahamRR, CotsapasC, DaviesL, HackettR, LessardCJ, et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40: 1059–1061.
80. Suarez-GestalM, CalazaM, EndreffyE, PullmannR, Ordi-RosJ, et al. (2009) Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 11: R69.
81. NamjouB, KothariPH, KellyJA, GlennSB, OjwangJO, et al. (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12: 270–279.
82. Lee-KirschMA, GongM, ChowdhuryD, SenenkoL, EngelK, et al. (2007) Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39: 1065–1067.
83. KozyrevSV, AbelsonAK, WojcikJ, ZaghloolA, Linga ReddyMV, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40: 211–216.
84. YuB, ChenY, WuQ, LiP, ShaoY, et al. (2011) The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin Rheumatol 30: 521–527.
85. HughesT, Kim-HowardX, KellyJA, KaufmanKM, LangefeldCD, et al. (2011) Fine mapping and transethnic geotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum 63: 1689–1697.
86. FernandoMM, FreudenbergJ, LeeA, MorrisDL, BotevaL, et al. (2012) Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis 71: 777–784.
87. BarcellosLF, MaySL, RamsayPP, QuachHL, LaneJA, et al. (2009) High density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions. PLoS Genet 5: e1000696 doi:10.1371/journal.pgen.1000696.
88. ZhangY, YangW, MokCC, ChanTM, WongRW, et al. (2011) Two missense variants in UHRF1BP1 are independently associated with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun 12: 231–234.
89. MusoneSL, TaylorKE, LuTT, NitithamJ, FerreiraRC, et al. (2008) Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 40: 1062–1064.
90. SigurdssonS, GöringHH, KristjansdottirG, MilaniL, NordmarkG, et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17: 872–881.
91. SigurdssonS, PadyukovL, KurreemanFA, LijedahlU, WimanAC, et al. (2007) Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 56: 2202–2210.
92. SigurdssonS, NordmarkG, GöringHH, LindroosK, WimanAC, et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76: 528–537.
93. GrahamRR, KozyrevSV, BaechlerEC, ReddyMV, PlengeRM, et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38: 550–555.
94. BudarfML, GoyetteP, BoucherG, LianJ, GrahamRR, et al. (2011) A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 12: 51–58.
95. LuR, VidalGS, KellyJA, Delgado-VegaAM, HowardXK, et al. (2009) Genetic associations of LYN with systemic lupus erythematosus. Genes Immun 10: 397–403.
96. RamosPS, CriswellLA, MoserKL, ComeauME, WilliamsAH, et al. (2011) A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 7: e1002406 doi:10.1371/journal.pgen.1002406.
97. LessardCJ, AdriantoI, KellyJA, KaufmanKM, GrundahlKM, et al. (2011) Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet 88: 83–91.
98. YangJ, YangW, HirankarnN, YeDQ, ZhangeY, et al. (2011) ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum Mol Genet 20: 601–607.
99. ShengYJ, GaoJP, LiJ, HanJW, XuQ, et al. (2011) Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatology 50: 682–688.
100. YangW, ShenN, YeDQ, LiuQ, ZhangY, et al. (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6: e1000841 doi:10.1371/journal.pgen.1000841.
101. MolinerosJE, Kim-HowardX, DeshmukhH, JacobCO, HarleyJB, et al. (2009) Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE. Genes Immun 10: 539–545.
102. VazgiourakisVM, ZervouMI, ChoulakiC, BertsiasG, MelissourgakiM, et al. (2011) A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis. Ann Rheum Dis 70: 2184–2190.
103. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824–828.
104. De JagerPL, JiaX, WangJ, de BakkerPI, OttoboniL, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776–782.
105. BaranziniSE, WangJ, GibsonRA, GalweyN, NaegelinY, et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 18: 767–778.
106. GregorySG, SchmidtS, SethP, OksenbergJR, HartJ, et al. (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39: 1083–91.
107. ComabellaM, CraigDW, Camiña-TatoM, MorcilloC, LopezC, et al. (2008) Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3: e3490 doi:10.1371/journal.pone.0003490.
108. International Multiple Sclerosis Genetics Consortium (2007) HaflerD, CompostonA, SawcerS, LanderES, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851–862.
109. JakkulaE, LeppäV, SulonenAM, VariloT, KallioS, et al. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 86: 285–291.
110. NischwitzS, CepokS, KronerA, WolfC, KnopM, et al. (2010) Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 227: 162–166.